Division News

Gow Arepally, MD, associate professor of medicine (Hematology) and pathology, is part of a team that received an inaugural MEDx Pilot Project Funding Program Award, which is designed to stimulate new collaborations, or support a new effort in an existing collaboration, between faculty from the Pratt School of Engineering and the School of Medicine.

Mary Klotman, MD, chair of the department, and Scott Palmer, MD, MHS, vice chair for research, have announced the recipients of the 2016 Chair’s Research Award.

The annual award funds junior investigators who are making the transition to becoming independent scientists prior to their acquisition of extramural funding.

Alexion Pharmaceuticals has pledged a $100,000 gift to establish the Wendell F. Rosse, MD, Complement Research Endowment in Hematology.

Marilyn Telen, MD, professor of medicine (Hematology), is Duke Today's Blue Devil of the Week.

Dr. Telen has been at Duke for 35 years doing basic and clinical research, which for the last 20 years has focused primarily on sickle cell disease, and training the next generation of hematologists. In the profile she shares the best advice she's ever been given, what she would do if she had $5 million and talks about her blog, MD on the Road. 

Faculty in the Division of Hematology have recently received notice of three exciting grants.

Brice Weinberg, MD, professor of medicine (Hematology), was awarded an NIH R01 grant for "Nitric Oxide and Microvascular Dysfunction in Severe Malaria."  This is a four-year grant that will begin in late September.  

Marilyn Telen, MD, professor of medicine (Hematology), received notice earlier this summer that her Hematology T32 training grant will be renewed for July 1, 2016-June 30, 2021. With this renewal, Dr. Telen will have 40 continuous years training investigators at Duke. 

Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patients who were given a “bridge” therapy, according to research led by Duke Medicine.

Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.

Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.

Marilyn Telen, MD leads small study that finds treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might be able to interfere with the underlying cause of these events, known as vaso-occlusion crises.

 

Medicine Grand Rounds on Fri., Oct. 10 at 8 a.m. in Duke Hospital room 2002 will feature Thom Ortel, MD, PhD, professor of medicine and pathology, chief of the Division of Hematology and medical director, Clinical Coagulation Laboratory. Dr. Ortel will present When Hoofbeats Aren't Horses.